About FDA
Percentage of manufacturing supplements requiring prior approval with action due dates occurring during the month that were reviewed and acted upon within 4 months of receipt
Dictionary: Licensed manufacturers must submit a prior approval supplement to FDA for any change to a biologic product that has a substantial impact to have an adverse effect on the identity, strength, quality, purity or potency of the product as they may relate to the safety or effectiveness of the product. Examples of such changes include the production process, quality controls, equipment, facilities, or responsible personnel. FDA approval must be obtained prior to distribution of the product made with the change. This measure will allow OBRR to monitor its performance in issuing decisions for manufacturing supplements requiring prior approval within established timeframes.
Information is current as of September 30, 2012
Fiscal Year - 2011
| Time | Target | Percent |
|---|---|---|
| Oct 2010 | 90 | 100 |
| Nov 2010 | 90 | 100 |
| Dec 2010 | 90 | 100 |
| Jan 2011 | 90 | 100 |
| Feb 2011 | 90 | 100 |
| Mar 2011 | 90 | 100 |
| Apr 2011 | 90 | 100 |
| May 2011 | 90 | 100 |
| Jun 2011 | 90 | 100 |
| Jul 2011 | 90 | 100 |
| Aug 2011 | 90 | 100 |
| Sep 2011 | 90 | 100 |
FY 2011 Overall: 100%
Number of manufacturing supplements requiring prior approval with action due dates occurring during the month that were reviewed and acted upon within 4 months of receipt
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 4 |
| Nov 2010 | N/A | 4 |
| Dec 2010 | N/A | 5 |
| Jan 2011 | N/A | 9 |
| Feb 2011 | N/A | 9 |
| Mar 2011 | N/A | 4 |
| Apr 2011 | N/A | 13 |
| May 2011 | N/A | 3 |
| Jun 2011 | N/A | 8 |
| Jul 2011 | N/A | 7 |
| Aug 2011 | N/A | 6 |
| Sep 2011 | N/A | 8 |
FY 2011 Total: 80
Number of manufacturing supplements requiring prior approval with action due dates occurring during the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 4 |
| Nov 2010 | N/A | 4 |
| Dec 2010 | N/A | 5 |
| Jan 2011 | N/A | 9 |
| Feb 2011 | N/A | 9 |
| Mar 2011 | N/A | 4 |
| Apr 2011 | N/A | 13 |
| May 2011 | N/A | 3 |
| Jun 2011 | N/A | 8 |
| Jul 2011 | N/A | 7 |
| Aug 2011 | N/A | 6 |
| Sep 2011 | N/A | 8 |
FY 2011 Total: 80
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
